Arlington Heights, IL, United States of America

Anthony V Pensa

This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2017.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Anthony V Pensa

Introduction

Anthony V Pensa is a notable inventor based in Arlington Heights, IL (US). He has made significant contributions to the field of neuroscience through his innovative work on 2-aminoquinoline-based compounds. With a total of 2 patents, his research focuses on the selective inhibition of neuronal nitric oxide synthase, which has important implications for various therapeutic applications.

Latest Patents

Pensa's latest patents include groundbreaking work on various 2-aminoquinoline compounds. These compounds are designed for potent and selective inhibition of neuronal nitric oxide synthase, which can be utilized both in vivo and in vitro. His research aims to provide effective solutions for conditions that involve nitric oxide dysregulation.

Career Highlights

Anthony V Pensa is affiliated with Northwestern University, where he continues to advance his research in the field. His work has garnered attention for its potential impact on neurological health and treatment options.

Collaborations

Pensa has collaborated with esteemed colleagues such as Richard B Silverman and Maris A Cinelli. These partnerships have further enriched his research and contributed to the development of innovative solutions in neuroscience.

Conclusion

Anthony V Pensa's contributions to the field of neuroscience through his patents and research at Northwestern University highlight his role as a significant inventor. His work on 2-aminoquinoline-based compounds showcases the potential for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…